CEO
SS
Salus Scientific Corp.
salus-science.com
Website unreachable since Oct 16, 2026
The startup develops organoid culture technology utilizing human pancreatic cancer cell lines to create a mouse model that enables high-throughput drug efficacy testing. This approach facilitates early diagnosis and treatment options for pancreatic cancer patients by rapidly evaluating potential therapies.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops organoid culture technology utilizing human pancreatic cancer cell lines to create a mouse model that enables high-throughput drug efficacy testing. This approach facilitates early diagnosis and treatment options for pancreatic cancer patients by rapidly evaluating potential therapies.